Total Voting Rights

Summary by AI ^BETAClose X

Morgan Advanced Materials PLC has announced its voting rights and capital as of 31 January 2026, stating that its share capital comprises 276,676,409 ordinary shares of 25 pence each with voting rights, and 437,281 cumulative preference shares of £1.00 each that do not carry voting rights except in limited circumstances. The company has cancelled 8,693,579 ordinary shares as part of its share buyback programme, which concluded on 9 January 2026. Shareholders can use the figure of 276,676,409 ordinary shares as the denominator for calculating their notification obligations under the Disclosure Guidance and Transparency Rules.

Disclaimer*

Morgan Advanced Materials PLC

02 February 2026

2 February 2026

Morgan Advanced Materials PLC (the "Company")

Voting Rights and Capital

The Company announces, in compliance with its obligations under Rules 5.6.1R and 5.6.2G of the FCA's Disclosure Guidance and Transparency Rules, that as at 31 January 2026, the Company's share capital consisted of:

· 276,676,409 Ordinary shares of 25 pence each, with equal voting rights; and

· 437,281 Cumulative Preference shares of £1.00 each, which do not carry voting rights, save in specified limited circumstances.

The Company does not hold any shares in Treasury.

Under the share buyback programme announced on 5 November 2024, and paused after the completion of the second tranche on 9 January 2026, the Company has purchased (and subsequently cancelled) 8,693,579 Ordinary shares.

The figure of 276,676,409 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's shares under the Disclosure Guidance and Transparency Rules.

Contact:

Win Chime, Group Company Secretary

Morgan Advanced Materials plc

company.secretariat@morganplc.com

The Company's LEI code is I4K14LL95N2PHDL7EG85.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END